Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Equity Ratio (2016 - 2025)

Skinvisible (SKVI) has disclosed Equity Ratio for 16 consecutive years, with 80.45 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 38.0% to 80.45 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 80.45 through Dec 2025, down 38.0% year-over-year, with the annual reading at 80.45 for FY2025, 38.0% down from the prior year.
  • Equity Ratio hit 80.45 in Q4 2025 for Skinvisible, down from 74.87 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 18.16 in Q2 2022 to a low of 80.45 in Q4 2025.
  • Historically, Equity Ratio has averaged 45.68 across 5 years, with a median of 45.03 in 2023.
  • Biggest five-year swings in Equity Ratio: increased 17.91% in 2022 and later plummeted 136.5% in 2023.
  • Year by year, Equity Ratio stood at 23.83 in 2021, then decreased by 12.93% to 26.91 in 2022, then plummeted by 105.89% to 55.4 in 2023, then dropped by 5.23% to 58.3 in 2024, then plummeted by 38.0% to 80.45 in 2025.
  • Business Quant data shows Equity Ratio for SKVI at 80.45 in Q4 2025, 74.87 in Q3 2025, and 68.03 in Q2 2025.